Expression of epidermal growth factor receptor and HER-2/neu in gastric carcinoma and their prognostic significance

被引：0
|
作者：
Gharesi-Fard, B
Vasei, M
Malekhosseini, SA
Modjtahedi, H
Ghaderi, A
机构：
[1] Shiraz Univ Med Sci, Dept Immunol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Pathol, Shiraz, Iran
[3] Shiraz Inst Canc Res, Shiraz, Iran
[4] Shiraz Univ Med Sci, Dept Surg, Shiraz, Iran
[5] Univ Surrey, European Inst Hlth & Med Sci, Surrey, England
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [21] IMMUNOHISTOCHEMICAL STUDY OF HER-2 NEU, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND STEROID-RECEPTOR EXPRESSION IN NORMAL AND MALIGNANT ENDOMETRIUM
    BIGSBY, RM
    LI, AX
    BOMALASKI, J
    STEHMAN, FB
    LOOK, KY
    SUTTON, GP
    OBSTETRICS AND GYNECOLOGY, 1992, 79 (01): : 95 - 100
  • [22] Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification
    Shin, Daniel Sanghoon
    Sherry, Timothy
    Kallen, Michael E.
    Wong, Steven
    Drakakia, Alexandra
    CASE REPORTS IN ONCOLOGY, 2016, 9 (02): : 298 - 304
  • [23] Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas
    Li, Qingguo
    Wang, Daorong
    Li, Jing
    Chen, Ping
    BMC CANCER, 2011, 11
  • [24] Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer
    Ferrandina, G
    Ranelletti, FO
    Lauriola, L
    Fanfani, F
    Legge, F
    Mottolese, M
    Nicotra, MR
    Natali, PG
    Zakut, VH
    Scambia, G
    GYNECOLOGIC ONCOLOGY, 2002, 85 (02) : 305 - 310
  • [25] Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas
    Qingguo Li
    Daorong Wang
    Jing Li
    Ping Chen
    BMC Cancer, 11
  • [26] Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features
    Erman, M
    Grunenwald, D
    Penault-Llorca, F
    Grenier, J
    Besse, B
    Validire, P
    Moret, L
    Girard, P
    Le Chevalier, T
    Sabatier, L
    Soria, JC
    LUNG CANCER, 2005, 47 (03) : 315 - 323
  • [27] Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study
    Tangjitgamol, S
    Ramirez, PT
    Sun, CC
    See, HT
    Jhingran, A
    Kavanagh, JJ
    Deavers, MT
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (04) : 646 - 656
  • [28] Prevalence and prognostic significance of HER2/neu and epidermal growth factor receptors in ovarian cancer
    Devitt, JL
    Chew, K
    Sauter, G
    Waldman, F
    Benz, CC
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (04) : 329 - 334
  • [29] Expression analyses of epidermal growth factor receptor and HER-2/neu: No advantage of prediction of recurrence or survival in breast cancer patients
    Beckmann, MW
    Niederacher, D
    Massenkeil, G
    Tutschek, B
    Beckmann, A
    Schenko, G
    Schnurch, HG
    Bender, HG
    ONCOLOGY, 1996, 53 (06) : 441 - 447
  • [30] Molecular oncogenesis of prostate adenocarcinoma: role of the human epidermal growth factor receptor 2 (HER-2/neu)
    Serpa Neto, Ary
    Tobias-Machado, Marcos
    Wroclawski, Marcelo Langer
    Affonso Fonseca, Fernando Luiz
    Lima Pompeo, Antonio Carlos
    Del Giglio, Auro
    TUMORI JOURNAL, 2010, 96 (05): : 645 - 649
12345